NCT00459576
- Conditions
- Asthma, Bronchial Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +15 more
- Locations
-
- Riley Hospital for Children Indianapolis, Indiana, United States
Clinical trial condition
Eczema
Explore clinical trials studying Eczema. Study availability and eligibility vary by location and protocol.
141 public trials
26 recruiting studies
Eczema trial results
NCT01420705
- Conditions
- Asthma, Bronchial Diseases, Dermatitis, +12 more
- Locations
-
- Bandim Health Project Bandim, Guinea-Bissau
NCT00375713
- Conditions
- Dermatitis, Eczema, Pathological Conditions, Signs and Symptoms, +6 more
- Locations
-
- Gyeunggi-do, South Korea
- Kyeonggi-Do, South Korea
- Seoul, South Korea
NCT01202149
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
- Locations
-
- Mount Sinai Faculty Practice Associates New York, United States
NCT01020994
- Conditions
- Dermatitis, Eczema, Skin Diseases, +2 more
- Locations
-
- Investigational Site Bochum, Germany
NCT00663364
- Conditions
- Dermatitis, Eczema, Skin Diseases, +2 more
- Locations
-
- Department of Dermatology Münster, North Rhine-Westphalia, Germany
NCT00438646
- Conditions
- Asthma, Bronchial Diseases, Dermatitis, +22 more
- Locations
-
- University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
Completed
Influence of Probiotics on Prevention of Atopy, Atopic Disease and Immunological Responses
NCT00318695
- Conditions
- Allergic Rhinitis, Asthma, Bronchial Diseases, +16 more
- Locations
-
- National University Hospital (NUH) Singapore
NCT00076375
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
- Locations
-
- Radiant Research Birmingham, Alabama, United States
- Medical Affliated Research Centers, Inc. Huntsville, Alabama, United States
- National Jewish Medical & Research Center Denver, Colorado, United States
- nTouch Research Washington D.C., District of Columbia, United States
Active, Not Recruiting
A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
NCT05559359
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
- Locations
-
- Clinical Research Center of Alabama Birmingham, Alabama, United States
- Phoenix Children's Hospital Phoenix, Arizona, United States
- Arkansas Research Trials North Little Rock, Arkansas, United States
- First OC Dermatology Fountain Valley, California, United States